LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

Search

Clearside Biomedical Inc

Cerrado

0.79

Resumen

Variación precio

24h

Actual

Mínimo

0.77

Máximo

0.8

Métricas clave

By Trading Economics

Ingresos

-917K

-8.2M

Ventas

2M

2.3M

BPA

-0.11

Margen de beneficio

-352.918

Empleados

32

EBITDA

-102K

-4.8M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+566.67% upside

Dividendos

By Dow Jones

Próximas Ganancias

11 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-9.7M

59M

Apertura anterior

0.79

Cierre anterior

0.79

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

Clearside Biomedical Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

12 jun 2025, 20:41 UTC

Ganancias

Adobe Raises Outlook After 2Q Sales Beat

12 jun 2025, 23:50 UTC

Ganancias

Adobe Keeps Pivoting as AI Transforms Customer Needs -- Update

12 jun 2025, 23:50 UTC

Ganancias

Adobe Customer Demand Shifting Toward Idea Generation, CFO Says

12 jun 2025, 23:50 UTC

Ganancias

Adobe FireFly Products Drove Revenue Beat in 2Q, CFO Says

12 jun 2025, 23:48 UTC

Charlas de Mercado

Gold Steady Amid Geopolitical Risks -- Market Talk

12 jun 2025, 23:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

12 jun 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

12 jun 2025, 21:26 UTC

Ganancias

Friedman Industries 4Q Sales $129.2M >FRD

12 jun 2025, 21:25 UTC

Ganancias

Friedman Industries 4Q EPS 76c >FRD

12 jun 2025, 21:11 UTC

Ganancias

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 jun 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

12 jun 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

12 jun 2025, 20:31 UTC

Ganancias

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 jun 2025, 20:30 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Chime IPO: Stock Soars in Nasdaq Debut, Valuing It at Nearly $14 Billion -- Barrons.com

12 jun 2025, 20:15 UTC

Ganancias

Adobe Sees FY25 Rev $23.5B-$23.6B >ADBE

12 jun 2025, 20:15 UTC

Ganancias

Adobe Sees 3Q Rev $5.88B-$5.93B >ADBE

12 jun 2025, 20:14 UTC

Ganancias

Adobe Stock Pops as Earnings Beat Estimates -- Barrons.com

12 jun 2025, 20:07 UTC

Ganancias

Adobe Raises FY25 Rev and EPS Targets

12 jun 2025, 20:05 UTC

Ganancias

Adobe Sees FY Adj EPS $20.50-Adj EPS $20.70 >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe 2Q Digital Experience Revenue $1.46B >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe 2Q Digital Media Revenue $4.35B >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe Sees 3Q EPS $4.00-EPS $4.05 >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe 2Q Net $1.69B >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe 2Q EPS $3.94 >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe 2Q Digital Experience Revenue Up 10% >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe 2Q Rev $5.87B >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe Sees 3Q Adj EPS $5.15-Adj EPS $5.20 >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe Sees FY EPS $16.30-EPS $16.50 >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe 2Q Digital Media Revenue Up 11% >ADBE

12 jun 2025, 20:05 UTC

Ganancias

Adobe 2Q Adj EPS $5.06 >ADBE

Comparación entre iguales

Cambio de precio

Clearside Biomedical Inc Esperado

Precio Objetivo

By TipRanks

566.67% repunte

Estimación a 12 meses

Media 5.4 USD  566.67%

Máximo 8 USD

Mínimo 3 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Clearside Biomedical Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

5

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

0.8417 / 0.8939Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Clearside Biomedical Inc

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.